Hemostatic Evaluation
Hemostatic Evaluation - Related Videos
08:40
TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
0 Views •
Cited by 12 •
2016
We describe the simplest protocol to prepare biodegradable medical glue that has an effective hemostatic ability. TAPE is a water-immiscible supramolecular aggregate prepared by mixing of tannic acid, a ubiquitous compound found in plants, and poly(ethylene) glycol, yielding a 2.5 times greater water-resistant adhesion compared with commercial fibrin glue.
04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
0 Views •
Cited by 1 •
2022
High-grade hemostatic devices are essential for laparoscopic hepatectomy. However, these devices are not generalized in basic medical organizations. Therefore, a suite of simple and easy hemostatic devices is shown in this article, which can make the laparoscopic hepatectomy easier to perform.
09:31
Evaluating the Procedure for Performing Awake Cystometry in a Mouse Model
0 Views •
Cited by 10 •
2017
This study describes the surgical procedures and experimental techniques for performing awake cystometry in a freely moving mouse. In addition, it provides experimental evidence to support its optimization and standardization.
08:04
Evaluating the Accuracy of Snap Judgments
0 Views •
2023
Source: Diego Reinero & Jay Van Bavel—New York University Social psychologists have long been interested in the way people form impressions of others. Much of this work has focused on the errors people make in judging others, such as the exaggerated influence of central traits (such as "warm" and "cold"), the insufficient weight given to the context in which others' behavior takes place, and the tendency for people to make judgments that conform to their initial expectations about another.
03:00
Self-Evaluation: Self-Enhancement and Self-Verification
0 Views •
2020
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
FAQs
The central distinction is whether a problem affects primary hemostasis or secondary hemostasis. Examining vessels and platelets addresses one part of bleeding control, while coagulation-pathway testing examines another. Separating these domains helps clinicians organize findings from the patient’s history and laboratory results when investigating unexplained bleeding, bruising, or other suspected hemostatic abnormalities.
Different measurements provide complementary information about hemostasis. Platelet counts, prothrombin time, activated partial thromboplastin time, fibrinogen measurement, and assays of clot formation or breakdown examine different components or stages of the process. Considering these results together gives clinicians a broader basis for identifying platelet disorders, coagulation factor deficiencies, or acquired abnormalities.
Laboratory results are interpreted alongside clinical history because the reason for evaluation can vary substantially. Unexplained bleeding, easy bruising, suspected thrombosis, preparation for an invasive procedure, and monitoring anticoagulant treatment each provide different clinical contexts. This combined assessment supports a more relevant interpretation than laboratory measurements considered in isolation.
A practical evaluation combines clinical information with targeted laboratory measurements. The workup may include a history of bleeding or bruising, platelet counts, prothrombin time, activated partial thromboplastin time, fibrinogen measurement, and assays assessing clot formation or breakdown. The selected information helps direct attention toward platelet-related, coagulation-related, or acquired abnormalities.
Clinicians may use this assessment when bleeding risk must be considered before surgery or another invasive procedure. Results can reveal abnormalities relevant to primary or secondary hemostasis and may contribute to planning safer care. The evaluation is especially useful when the clinical history or existing findings raise concern about unexplained bleeding, bruising, or abnormal clotting.
Laboratory assessment can help guide monitoring of anticoagulant treatment while also evaluating possible bleeding or clotting concerns. Interpreting test results with the patient’s clinical history supports risk assessment rather than relying on a single measurement. In medicine, this information contributes to safer decisions tailored to the individual, including care surrounding procedures.